In fact, the ICMR is making progress on multiple fronts. The Indian Council for Medical Research (ICMR) has recently announced research collaboration with Hyderabad-based Bharat Biotech International Ltd (BBIL) to develop a COVID-19 vaccine. The ICMR even confirmed that it had transferred the virus strain isolated at the National Institute of Virology, Pune (an ICMR affiliate) to BBIL for further work on this subject. ICMR and BBIL will now seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine. This entire exercise will be wholly indigenous. This is BBIL’s third initiative in developing a COVID-19 vaccine. As part of the plan, BBIL proposes to manufacture the vaccine, conduct clinical trials and prepare to produce almost 300 million doses of vaccine for global distribution.